Quarterly
Annual
| Unit: USD | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
revenue | 51,242,000 | 48,484,000 | 47,270,000 | 44,435,000 | 45,298,000 | 40,131,000 | 40,071,000 | 37,374,000 | 33,173,000 | 28,021,000 | 28,265,000 | 24,701,000 | 26,456,000 | 22,053,000 | 21,134,000 | 20,067,000 | 15,094,000 | 18,933,000 | 18,633,000 | 17,026,000 | 14,928,000 | 12,766,000 |
yoy | 13.12% | 20.81% | 17.97% | 18.89% | 36.55% | 43.22% | 41.77% | 51.31% | 25.39% | 27.06% | 33.74% | 23.09% | 75.27% | 16.48% | 13.42% | 17.86% | 1.11% | 48.31% | ||||
qoq | 5.69% | 2.57% | 6.38% | -1.91% | 12.88% | 0.15% | 7.22% | 12.66% | 18.39% | -0.86% | 14.43% | -6.63% | 19.97% | 4.35% | 5.32% | 32.95% | -20.28% | 1.61% | 9.44% | 14.05% | 16.94% | |
cost of goods sold | 12,736,000 | 11,983,000 | 12,468,000 | 12,050,000 | 13,004,000 | 12,526,000 | 10,979,000 | 9,308,000 | 9,012,000 | 8,577,000 | 7,233,000 | 6,076,000 | 6,598,000 | 5,538,000 | 5,217,000 | 5,488,000 | 5,336,000 | 5,250,000 | 4,721,000 | 4,170,000 | 3,697,000 | 3,339,000 |
gross profit | 38,506,000 | 36,501,000 | 34,802,000 | 32,385,000 | 32,294,000 | 27,605,000 | 29,092,000 | 28,066,000 | 24,161,000 | 19,444,000 | 21,032,000 | 18,625,000 | 19,858,000 | 16,515,000 | 15,917,000 | 14,579,000 | 9,758,000 | 13,683,000 | 13,912,000 | 12,856,000 | 11,231,000 | 9,427,000 |
yoy | 19.24% | 32.23% | 19.63% | 15.39% | 33.66% | 41.97% | 38.32% | 50.69% | 21.67% | 17.74% | 32.14% | 27.75% | 103.50% | 20.70% | 14.41% | 13.40% | -13.12% | 45.15% | ||||
qoq | 5.49% | 4.88% | 7.46% | 0.28% | 16.99% | -5.11% | 3.66% | 16.16% | 24.26% | -7.55% | 12.92% | -6.21% | 20.24% | 3.76% | 9.18% | 49.41% | -28.69% | -1.65% | 8.21% | 14.47% | 19.14% | |
gross margin % | 75.15% | 75.28% | 73.62% | 72.88% | 71.29% | 68.79% | 72.60% | 75.09% | 72.83% | 69.39% | 74.41% | 75.40% | 75.06% | 74.89% | 75.31% | 72.65% | 64.65% | 72.27% | 74.66% | 75.51% | 75.23% | 73.84% |
operating expenses: | ||||||||||||||||||||||
research and development | 11,883,000 | 10,660,000 | 10,064,000 | 10,047,000 | 10,780,000 | 10,433,000 | 9,200,000 | 8,471,000 | 10,655,000 | 8,123,000 | 7,499,000 | 6,867,000 | 7,261,000 | 5,484,000 | 10,039,000 | 4,711,000 | 3,393,000 | 3,131,000 | 3,264,000 | 3,187,000 | 3,113,000 | 2,707,000 |
selling, general and administrative | 43,818,000 | 40,775,000 | 39,110,000 | 36,009,000 | 35,830,000 | 34,082,000 | 32,522,000 | 28,821,000 | 27,700,000 | 27,275,000 | 27,595,000 | 25,049,000 | 22,549,000 | 21,194,000 | 20,872,000 | 19,202,000 | 15,758,000 | 19,692,000 | 18,156,000 | 17,064,000 | 14,135,000 | 13,866,000 |
total operating expenses | 55,701,000 | 51,435,000 | 49,174,000 | 46,056,000 | 46,610,000 | 44,515,000 | 41,722,000 | 37,292,000 | 38,355,000 | 35,398,000 | 35,094,000 | 31,916,000 | 29,810,000 | 26,678,000 | 30,911,000 | 23,913,000 | 19,151,000 | 22,823,000 | 21,420,000 | 20,251,000 | 17,248,000 | 16,573,000 |
income from operations | -17,195,000 | -14,934,000 | -14,372,000 | -13,671,000 | -14,316,000 | -16,910,000 | -12,630,000 | -9,226,000 | -14,194,000 | -15,954,000 | -14,062,000 | -13,291,000 | -9,952,000 | -10,163,000 | -14,994,000 | -9,334,000 | -9,393,000 | -9,140,000 | -7,508,000 | -7,395,000 | -6,017,000 | -7,146,000 |
yoy | 20.11% | -11.69% | 13.79% | 48.18% | 0.86% | 5.99% | -10.18% | -30.58% | 42.62% | 56.98% | -6.22% | 42.39% | 5.95% | 11.19% | 99.71% | 26.22% | 56.11% | 27.90% | ||||
qoq | 15.14% | 3.91% | 5.13% | -4.51% | -15.34% | 33.89% | 36.90% | -35.00% | -11.03% | 13.45% | 5.80% | 33.55% | -2.08% | -32.22% | 60.64% | -0.63% | 2.77% | 21.74% | 1.53% | 22.90% | -15.80% | |
operating margin % | -33.56% | -30.80% | -30.40% | -30.77% | -31.60% | -42.14% | -31.52% | -24.69% | -42.79% | -56.94% | -49.75% | -53.81% | -37.62% | -46.08% | -70.95% | -46.51% | -62.23% | -48.28% | -40.29% | -43.43% | -40.31% | -55.98% |
interest income | 2,321,000 | 2,471,000 | 2,618,000 | 2,617,000 | 2,434,000 | 2,287,000 | 1,776,000 | 617,000 | 122,000 | 12,000 | 15,000 | 42,000 | 47,000 | 95,000 | 153,000 | 249,000 | 299,000 | 404,000 | 441,000 | 565,000 | 598,000 | 52,000 |
interest expense | -1,725,000 | -1,721,000 | -1,734,000 | -1,732,000 | -1,712,000 | -1,693,000 | -1,732,000 | -1,714,000 | -1,031,000 | -621,000 | -634,000 | -633,000 | -628,000 | -623,000 | -791,000 | -1,215,000 | -1,203,000 | -1,202,000 | -1,216,000 | -1,176,000 | -1,207,000 | -1,352,000 |
other income | -4,000 | 48,000 | 477,000 | -2,000 | 110,000 | -144,000 | -28,000 | 4,000 | -50,000 | -116,000 | -12,000 | -3,000 | -6,000 | -3,000 | -6,000 | -15,000 | -56,000 | -3,000 | -8,000 | -1,000 | -5,333,000 | -15,712,000 |
net income | -16,603,000 | -14,136,000 | -13,011,000 | -12,788,000 | -13,484,000 | -16,460,000 | -12,614,000 | -10,319,000 | -15,398,000 | -16,679,000 | -14,693,000 | -13,885,000 | -10,539,000 | -10,694,000 | -16,757,000 | -10,315,000 | -10,353,000 | -9,941,000 | ||||
yoy | 23.13% | -14.12% | 3.15% | 23.93% | -12.43% | -1.31% | -14.15% | -25.68% | 46.10% | 55.97% | -12.32% | 34.61% | 1.80% | 7.57% | ||||||||
qoq | 17.45% | 8.65% | 1.74% | -5.16% | -18.08% | 30.49% | 22.24% | -32.98% | -7.68% | 13.52% | 5.82% | 31.75% | -1.45% | -36.18% | 62.45% | -0.37% | 4.14% | |||||
net income margin % | -32.40% | -29.16% | -27.52% | -28.78% | -29.77% | -41.02% | -31.48% | -27.61% | -46.42% | -59.52% | -51.98% | -56.21% | -39.84% | -48.49% | -79.29% | -51.40% | -68.59% | -52.51% | 0% | 0% | 0% | 0% |
other comprehensive loss: | ||||||||||||||||||||||
unrealized loss on investments | -105,000 | |||||||||||||||||||||
other comprehensive income loss | -105,000 | |||||||||||||||||||||
comprehensive loss | -16,708,000 | -14,225,000 | ||||||||||||||||||||
net income per share | -0.42 | -0.36 | -0.34 | -0.33 | -0.35 | -0.43 | -0.33 | -0.29 | -0.44 | -0.48 | -0.42 | -0.4 | -0.31 | -0.31 | -0.5 | -0.31 | -0.32 | -0.32 | -0.1 | -0.26 | -0.42 | -20.12 |
weighted-average common shares used to compute net income per share, basic and diluted | 39,620,888 | 39,261,496 | 38,804,343 | 38,865,011 | 38,765,166 | 38,532,202 | 35,775,672 | 35,303,958 | 35,143,178 | 35,023,297 | 34,635,358 | 34,736,015 | 34,534,099 | 34,336,433 | 33,757,599 | 32,682,360 | 31,338,310 | 30,764,354 | 28,458,793 | 1,200,719 | ||
other comprehensive income: | ||||||||||||||||||||||
unrealized gain on investments | -89,000 | 356,000 | 47,000 | -9,500 | -2,000 | -3,000 | -33,000 | -113,000 | -164,000 | -126,000 | ||||||||||||
other comprehensive income | -89,000 | |||||||||||||||||||||
loss on debt extinguishment | -245,000 | |||||||||||||||||||||
other comprehensive loss | -29,500 | 47,000 | -414,000 | |||||||||||||||||||
net income and comprehensive loss | -10,712,500 | -12,741,000 | -13,898,000 | -16,211,000 | -12,589,000 | -10,508,000 | -15,400,000 | -16,679,000 | -14,694,000 | -13,887,000 | -10,542,000 | -10,727,000 | -7,614,500 | -10,479,000 | -10,479,000 | -9,501,000 | -11,031,000 | -8,007,000 | -11,959,000 | -24,158,000 | ||
change in unrealized loss on investments | -414,000 | |||||||||||||||||||||
change in unrealized gain on investments | 249,000 | 25,000 | -189,000 | -2,000 | ||||||||||||||||||
net change in other comprehensive loss | 249,000 | 25,000 | -189,000 | -2,000 | -1,000 | -2,000 | -3,000 | -33,000 | -113,000 | -164,000 | -126,000 | 440,000 | ||||||||||
unrealized gains on investments | 440,000 | |||||||||||||||||||||
net income and comprehensive loss attributable to non-controlling interest | ||||||||||||||||||||||
net income and comprehensive loss attributable to silk road medical, inc. common stockholders | -8,289,000 | -8,007,000 |
The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
